Company Profile
Envisagenics
Headquarters
New York, USA
Year Founded
2014
Top Impacted Industries
Pharmaceuticals, Biotechnology, Drug Discovery, Healthcare, Life Sciences
About Us
Envisagenics develops AI-powered drug discovery technology focused on RNA splicing. Its SpliceCore platform analyzes large-scale RNA sequencing data to identify disease-specific therapeutic targets, with research focused on oncology and neurodegenerative diseases. The company also develops RNA therapeutics and partners with biopharmaceutical organizations to advance drug discovery.
Related Articles
Trending Companies
Latest Articles
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2026 All Rights Reserved.